It is likely that PPARα activation ameliorates VPA-induced hepatotoxicity through its regulation of β-FAO genes, including CPT1A, CPT2 and LCAD. Activation of PPARα reduces VPA-induced lipid and ACs accumulation in multiple components and ameliorates fatty liver injury. The gene discussed is CPT2; the disease is fatty liver disease.